key: cord-0824715-5xus3s5k authors: Mantagos, Iason S.; Wu, Carolyn; Griffith, Joseph F.; Jastrzembski, Benjamin G.; Gonzalez, Efren; Goldstein, Samantha; Pearlo, Lori; Vanderveen, Deborah K. title: Retinopathy of prematurity screening and risk mitigation during the COVID-19 pandemic date: 2021-04-18 journal: J AAPOS DOI: 10.1016/j.jaapos.2020.11.015 sha: 9164c4dbd5b300bf849cca09249361acf77904e5 doc_id: 824715 cord_uid: 5xus3s5k Background The coronavirus disease 2019 (COVID-19) pandemic has significantly disrupted the delivery of healthcare. Although most nonurgent ophthalmology visits at Boston Children’s Hospital were canceled, premature infants at risk for retinopathy of prematurity (ROP) still required timely, in-person care during the initial 3-month period of the infection surge in Massachusetts. The purpose of the current study was to report our protocols for mitigating risk of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between infants and eye care providers and to compare examination rates and results with the same 3-month period in 2019. Methods During the infection surge, we added new infection control measures and strengthened existing ones. Additional personal protective equipment was used, and the number of ophthalmologists rotating in the three high-capacity NICUs we service was limited. Results More infants required ROP examinations during the study period in 2020 than in the same period in 2019, but fewer examinations were performed. There were no cases of missed progression to severe ROP during this time and no known transmission of SARS-CoV-2 between ROP patients and ophthalmology staff. Conclusions Overall, effective ROP care was safely provided during the COVID-19 pandemic, and contact with this vulnerable population was minimized. Retinopathy of prematurity (ROP) is a common and potentially blinding disease that affects the developing retinal vasculature of premature infants and can cause tractional retinal detachment. Detection and management of ROP warranting treatment requires timely and effective screening. In the United States, premature babies born at <30 weeks' gestational age (GA) or with birth weight (BW) of ≤1,500 g, and those whose medical course has been deemed complex enough to be a risk factor for ROP by their attending pediatrician or neonatologist are screened for ROP. 1 The coronavirus disease 2019 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to significant disruption in the delivery of healthcare. [2] [3] [4] [5] While most children with SARS-CoV-2 infection have mild symptoms, infants can still develop early-onset SARS-CoV-2 infection 6 and children can develop life-threatening disease, including a recently recognized multisystem inflammatory syndrome associated with COVID-19. 7, 8 Infection control in neonatal intensive care units (NICU) is a critical aspect of perinatal care; however, ROP screening examinations have unfortunately been associated with other viral outbreaks. 9 Given the blinding potential of ROP, ophthalmologists had to adapt their practice patterns to ensure continued delivery of care without compromising the safety of patients, colleagues, and themselves. We describe the measures taken by the Department of Ophthalmology at Boston Children's Hospital to mitigate the risk of SARS-CoV-2 transmission during ROP screening. 3 months of infection surge in Massachusetts, starting the week of March 16, 2020, the Monday after a state of emergency was declared by the governor. 10 The measures described here are in addition to hospital-wide measures implemented by the three separate NICUs our service covers for in-person examinations. Although we also provide telemedicine ROP screening, our practice for screening these patients did not change, because images were captured by the neonatology service; we did not have to implement specific measures for the ophthalmology staff to follow. Infants discharged from NICUs where tele-screening was performed were then followed as outpatients, and at that point our updated departmental protocols were applied. Descriptive statistics were used to compare the number of examinations performed and patients treated for ROP during the same 3-month period during 2019. Common infection control measures at all three hospitals included screening of all staff for J o u r n a l P r e -p r o o f COVID-19 symptoms at the start of each shift, universal use of ear-loop masks, and enhanced personal protective equipment (PPE) use (N95 respirators, face shields, gowns, and gloves) for care of patients with suspected or confirmed COVID-19, or for patients undergoing aerosolgenerating procedures. Staff did not undergo routine SARS-CoV-2 testing unless symptomatic. It has been standard practice at our institutions to use a sterile ROP eye examination kit, that includes a scleral depressor and lid speculum, for each patient; this practice continued during the COVID-19 pandemic. All visitors to the hospitals were screened at entry points and mask wear was mandatory.  A new rotation schedule was created: not all the ophthalmologists would round each week, and each ophthalmologist would round at only one NICU.  ROP nurses no longer accompanied ophthalmologists on rounds; assistance for infant positioning was provided by the bedside nurse.  Fellows and residents no longer participated in ROP rounds.  Ophthalmologists started wearing hospital-issued scrubs that were provided at the start of each shift and would be disposed at the hospital at the end of the shift.  Indirect ophthalmoscopes were disinfected with hydrogen peroxide wipes and 28 D lenses were cleaned with soap and water between patients.  Retinal photography was limited to severe cases of ROP nearing treatment for evaluation of subtle changes between examinations.  Family counseling was provided via teleconferencing applications or via telephone to minimize face-to-face interactions.  Even prior to the COVID-19 pandemic, we were using the WINROP algorithm for risk-J o u r n a l P r e -p r o o f stratification of premature babies. 11 During the COVID-19 pandemic, we increased utilization of the WINROP risk-stratification algorithm to extend the length of follow-up when possible (eg, an older, WINROP negative premature infant who was found to be immature in zone II might be scheduled for a 3-week instead of a 2-week follow-up).  Prior to the COVID-19 pandemic, it was not uncommon to follow patients until full retinal vascularization had occurred or they were at least 44 weeks postmenstrual age (PMA) with unequivocally regressing ROP in keeping with the current national screening criteria. 1 During the COVID-19 pandemic, we concluded examinations early whenever possible to avoid outpatient visits (eg, low-risk WINROP negative infants with no history of ROP, in zone III, who were at least 36 weeks PMA at the time of their last ROP examination).  A protocol was developed with each NICU to allow for infants who required outpatient ROP follow-up to either have a prescription for dilating drops (cyclopentolate 1%) sent to their pharmacy, or have dilating drops for outpatient use given to the caregiver prior to hospital discharge. NICU bedside nurses educated caregivers about the use of dilating drops. One set of dilating drops were placed one hour prior to the scheduled outpatient eye appointment, so eyes were predilated for the visit to minimize time spent in clinic. Hospital-directed measures included closing satellite clinics to maintain PPE supplies. The number of caregivers accompanying infants to appointments was limited to 2 adults, and other children, including siblings, were not permitted. Visitor screening for COVID-19 symptoms occurred at the hospital main entrance, and masks were required. Prearrival electronic check-in was encouraged to minimize check-in time, Plexiglas barriers were placed at check-in desks to J o u r n a l P r e -p r o o f minimize droplet dispersion, and verbal instead of written consent was obtained by administrative staff for billing authorization and acceptance of HIPAA/hospital privacy notices.  ROP nurses would call families 2-3 days in advance of their appointment to perform a health screening, review instructions for use of dilating drops, and provide caregiver education. If families had not received a prescription for dilating drops at discharge one was called-in to their pharmacy.  Appointment templates were changed to maximize physical distancing by having one patient arrive every 30 minutes.  On arrival and check-in patients were escorted directly to an exam room without having to wait in the waiting room.  Patients arriving early were asked to call prior to entering and to wait outside or in the outside lobby until their scheduled appointment. ROP is a potentially blinding disease that requires timely screening and treatment, and neither screening nor treatment could be postponed during the COVID-19 pandemic. The ophthalmology service at our institution sought to mitigate the risk of SARS-CoV-2 transmission during the COVID-19 surge in Massachusetts and adapted our screening protocols, while continuing to follow national ROP screening criteria. 1 We did not have any cases of transmission of SARS-CoV-2 during ROP examinations. Although we cared for 18% more inpatients during the 3-month period from March 16, 2020, to June 16, 2020, than during the same 3-month period in 2019, we performed 19% fewer inpatient examinations. In addition, 46% fewer infants required outpatient follow-up in 2020. Infants at higher risk (generally <28 weeks, birthweight <1250 g, WINROP positive) or with high-risk characteristics on examination (zone I or posterior zone II ROP, pre-plus disease, stage 2 or 3 ROP) were followed closely, according to pre-COVID practice, and eyes with type I ROP received timely treatment, with no progression to retinal detachment. Infants with older GA, higher BW, WINROP negative, and no concerning features on examination were followed at longer intervals. The reduction in examinations, therefore, was in effect the result of tighter implementation of screening guidelines, not requiring following patients to full maturity if they never had active ROP, as well as by better use of the WINROP risk-stratification algorithm. The effect of risk-stratification algorithms to the number of required ROP screening examinations has been well documented in the literature. 12 The main mode of SARS-Cov-2 infection is thought to be contact and droplet transmission, while fomite transmission is considered a likely mode of transmission, and airborne transmission is less likely to occur. 13 Intrauterine vertical transmission of SARS-CoV-2 from infected mothers is unlikely, 14, 15 as well as transmission of SARS-CoV-2 to infants from SARS-CoV-2 positive mothers as long as appropriate hygiene measures are followed. 16 Of particular concern for ophthalmologists is that SARS-CoV-2 has been detected in tears and transmission of SARS-CoV-2 from tears to the respiratory tract by means of the nasolacrimal system is possible. 17,18 SARS-CoV-2 transmission to healthcare workers can occur and is a particular occupational hazard to ophthalmologists, because hemorrhagic conjunctivitis is a manifestation of COVID-19 in newborns and because the ophthalmic examination requires close proximity to the face. 19, 20, 21 We had concerns that ophthalmologists could be exposed in the clinics and be asymptomatic carriers to the NICU population. Rarely, other viral outbreaks have occurred in the NICU as a result of the ROP examination, 9 and thus we determined an adjustment to how we approach ROP screening during the COVID-19 pandemic was required. Although doable, it can be difficult to fit the indirect ophthalmoscope over face shields. It was easier to fit the ophthalmoscope over safety goggles, but the fit of goggles over spectacles should be assessed, as visualization can be limited, particularly if the fit is not tight, and condensation develops. We are not sure whether goggles provide the same level of protection compared to the face shields. Out of an abundance of caution, during the 3-month surge, we were required by our institution to use a new bottle of mydriatic and topical anesthetic drops for each outpatient. This can be expensive, to the point of the cost of eye drops being greater than reimbursement for the examinations. With no evidence for disease transmission via eyedrops if appropriate measures are taken when handling them, this practice has since been discontinued. 22 There are concerns about the safety of mydriatic eye drop administration to premature infants at home and the risk of apnea and systemic side effects. 23 The decision to proceed with at-home dilation prior to the eye clinic appointment was made in conjunction with the neonatology service prior to discharge, and patients had to be stable and without an apneic spell for at least 7 days prior to discharge. We avoided phenylephrine-containing drops, which are known to affect heart rate and blood pressure in young children. The detrimental educational effect of limiting trainee exposure to the ROP examinations during the 3-month surge has to be considered. This would not be sustainable for longer periods of time, especially considering the shortage of ophthalmologists with expertise in performing ROP examinations. 24 We did experience significant resistance from many families about bringing their infants to clinic for outpatient ROP examinations; however, all of them had follow-ups within the recommended time frame. The ROP nursing team was instrumental in ensuring that infants were J o u r n a l P r e -p r o o f not lost to follow-up by communicating directly with families, addressing their concerns, and reassuring them by explaining the specific safety measures we had put in place. At times we connected families with our social worker to address social barriers and inform families about the possibility of having the Department of Children and Families involved if parents failed to bring infants for follow-up. As clinic volume is expected to increase, the modified clinic templates, with outpatients staggered every 30 minutes, is not sustainable in the long term; the ability to provide outpatient ophthalmologic care has been reduced by 50% and has created a large back-log of visits for pediatric ophthalmic care. It is possible that transitioning to remote screening, where NICU-based staff obtains retinal images would further decrease exposure from the ophthalmology team. In this scenario, increased number of imaging sessions would be required, but would be performed by NICU staff, and ophthalmologists would only perform bedside examinations for referral-warranted ROP or other concerns. 25 Because we are still in the COVID-19 pandemic, it is important to continue risk mitigation. Best practices entail using PPE, physical distancing, and prioritizing clinical care to life-and vision-threatening conditions. Predilation of select infants for outpatient screening can be considered to aid social distancing, by minimizing time spent in clinic. The use of riskstratification algorithms should be considered to reduce examinations for low-risk infants. 12 Telemedicine ROP screening is effective 26 and can also be considered to minimize the need for ophthalmologists to physically enter the NICU. J o u r n a l P r e -p r o o f American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China A novel coronavirus from patients with pneumonia in China Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States WHO Director-General's opening remarks at the media briefing on COVD-19-11 Review of maternal COVID-19 infection: considerations for the pediatric ophthalmologist Multisystem inflammatory syndrome in U.S. children and adolescents Multisystem inflammatory syndrome in children in New York state Outbreak of adenovirus in a neonatal intensive care unit: critical importance of equipment cleaning during inpatient ophthalmologic examinations Declaration of a state of emergency to respond to COVID-19 Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity Algorithms for the prediction of retinopathy of prematurity based on postnatal weight gain Transmission of SARS-CoV-2-implications for infection prevention precautions: scientific brief Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Novel coronavirus disease (COVID-19) in newborns and infants: what we know so far Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report The possibility of COVID-19 transmission from eye to nose Ophthalmic manifestations associated with SARS-CoV-2 in newborn infants: a preliminary report. E-pub ahead of print COVID-19 and ophthalmology: an underappreciated occupational hazard Monitoring approaches for health-care workers during the COVID-19 pandemic Important coronavirus updates for ophthalmologists Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams Staggering ROP awards scaring doctors away